BHCM
THC icon

Brevan Howard Capital Management’s Tenet Healthcare THC Stock Holding History

Brevan Howard Capital Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.15M Sell
11,483
-5,497
-32% -$1.01M 0.02% 691
2026
Q1 		$3.2M Buy
16,980
+10,633
+168% +$2.24M 0.03% 386
2025
Q4 		$1.26M Sell
6,347
-19,190
-75% -$3.88M 0.01% 662
2025
Q3 		$5.19M Sell
25,537
-12,406
-33% -$2.2M 0.02% 231
2025
Q2 		$6.68M Buy
37,943
+32,088
+548% +$4.83M 0.04% 272
2025
Q1 		$787K Sell
5,855
-18,209
-76% -$2.4M 0.01% 581
2024
Q4 		$3.04M Buy
24,064
+10,094
+72% +$1.5M 0.02% 208
2024
Q3 		$2.32M Sell
13,970
-7,651
-35% -$1.16M 0.02% 244
2024
Q2 		$2.88M Buy
21,621
+19,706
+1,029% +$2.37M 0.03% 150
2024
Q1 		$201K Sell
1,915
-3,005
-61% -$270K ﹤0.01% 800
2023
Q4 		$372K Buy
+4,920
New +$312K ﹤0.01% 622

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Brevan Howard Capital Management's THC Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Tenet Healthcare (THC) stake by 32% in Q2 2026, selling an estimated $1.01M and leaving 11,483 shares worth $2.15M. The position accounts for 0.02% of the portfolio, ranked #691.

Brevan Howard Capital Management first reported a position in THC in Q4 2023 and has held it in 11 quarters since. The position peaked at $6.68M in Q2 2025. 673 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Brevan Howard Capital Management held 11,483 shares of Tenet Healthcare worth $2.15M as of Q2 2026.
  • Brevan Howard Capital Management sold 5,497 Tenet Healthcare shares in Q2 2026, an estimated $1.01M.
  • Tenet Healthcare made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #691 holding.
  • Brevan Howard Capital Management first reported a position in Tenet Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Brevan Howard Capital Management's Tenet Healthcare position peaked at $6.68M in Q2 2025.
  • 673 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.